Skip to content

Organon OGN Earnings yield

Earnings yield at other companies

Pfizer logo
PfizerPFE
6.8%
Amgen logo
AmgenAMGN
4.1%+0.6pp
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
1.9%-0.6pp
Biogen logo
BiogenBIIB
5.3%-2.1pp
AbbVie logo
AbbVieABBV
0.9%-0.2pp
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
3.1%+2.7pp

Other financials

Income statement

See full
Revenue$1.5B-3.5%
Gross profit$783.0M-6.9%
Net income$146.0M+67.8%
EPS (diluted)$0.55+66.7%

Balance sheet

See full
Cash & equivalents$1.1B+104%
Total debt$8.6B-4.3%
Total equity$903.0M+66.6%
Total assets$13.0B-1.2%

Cash flow

See full
Operating cash flow$225.0M+200%
CapEx$37.0M+15.6%
Free cash flow$188.0M+337%

Valuation

See full
Market cap$3.53B-59.4%

Profitability

See full
Gross margin52.8%-4.4pp
Net margin8%-12.3pp
FCF margin11.1%-1.3pp

Returns & leverage

See full
Return on equity71.6%
Debt / equity9.5×-7.0×
Current ratio+0.3×

Where this comes from

Calculated from Organon’s reported figures.

Based on trailing twelve months.

The official record: Organon’s 10-Q, filed November 10, 2025, on SEC EDGAR. View the filing →

Ask your AI about Organon's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Organon's earnings yield?
Organon (OGN) reported earnings yield of 18% in Q3 2025.
How has Organon's earnings yield changed year-over-year?
Organon's earnings yield decreased by 31.7% year-over-year, from 26.4% to 18%.
What is the long-term trend for Organon's earnings yield?
Over 3 years (2021 to 2024), Organon's earnings yield has grown at a 8.7% compound annual growth rate (CAGR), from 17.5% to 22.5%.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.